End-point selection to determine the airway-systemic ratio of inhaled corticosteroids in asthma
© 2020 British Pharmacological Society..
The use of adenosine monophosphate challenge and basal cortisol as short-term surrogate end points of airway-systemic effects of inhaled corticosteroids in asthma is not suitable to properly determine the clinically relevant long-term therapeutic index.
| Errataetall: |
CommentOn: Br J Clin Pharmacol. 2021 Feb;87(2):483-493. - PMID 32484940 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:87 |
|---|---|
| Enthalten in: |
British journal of clinical pharmacology - 87(2021), 5 vom: 10. Mai, Seite 2401-2402 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lipworth, Brian [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adrenal Cortex Hormones |
|---|
| Anmerkungen: |
Date Completed 20.09.2021 Date Revised 20.09.2021 published: Print-Electronic CommentOn: Br J Clin Pharmacol. 2021 Feb;87(2):483-493. - PMID 32484940 Citation Status MEDLINE |
|---|
| doi: |
10.1111/bcp.14633 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM317977636 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM317977636 | ||
| 003 | DE-627 | ||
| 005 | 20231225164406.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/bcp.14633 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1059.xml |
| 035 | |a (DE-627)NLM317977636 | ||
| 035 | |a (NLM)33230858 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lipworth, Brian |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a End-point selection to determine the airway-systemic ratio of inhaled corticosteroids in asthma |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.09.2021 | ||
| 500 | |a Date Revised 20.09.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Br J Clin Pharmacol. 2021 Feb;87(2):483-493. - PMID 32484940 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 British Pharmacological Society. | ||
| 520 | |a The use of adenosine monophosphate challenge and basal cortisol as short-term surrogate end points of airway-systemic effects of inhaled corticosteroids in asthma is not suitable to properly determine the clinically relevant long-term therapeutic index | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
| 650 | 7 | |a Anti-Asthmatic Agents |2 NLM | |
| 650 | 7 | |a Hydrocortisone |2 NLM | |
| 650 | 7 | |a WI4X0X7BPJ |2 NLM | |
| 700 | 1 | |a Chan, Rory |e verfasserin |4 aut | |
| 700 | 1 | |a Kuo, Chris Rui Wen |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t British journal of clinical pharmacology |d 1974 |g 87(2021), 5 vom: 10. Mai, Seite 2401-2402 |w (DE-627)NLM000097799 |x 1365-2125 |7 nnns |
| 773 | 1 | 8 | |g volume:87 |g year:2021 |g number:5 |g day:10 |g month:05 |g pages:2401-2402 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/bcp.14633 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 87 |j 2021 |e 5 |b 10 |c 05 |h 2401-2402 | ||